The many hot takes on here that the complications from J&J are so rare we shouldn’t have paused it’s use are persuasive at face value. The pandemic IS still raging. We NEED shots in arms. And the risk is SO low! This is all true.
But that argument is missing something critical.
If my loved one was among the 6 with a complication AND the FDA/CDC/US govt knew there was a signal but didn’t act, I’d be furious.
I really appreciate the transparency here.
They could’ve easily argued this away...”this is the background rate of clots” etc. But they didn’t.
Will this mean it’ll be harder to convince many, especially younger women, to get the J&J vaccine if/when we start using it widely again? Yes.
...even if the risk is shown to be much lower than Covid, getting struck by lighting, or dying from a vending machine crushing you? Yes.
But the practical importance of this pause - and how it was messaged, with a focus on informing providers - was huge. And really responsible.
I was in the ER today. One of the first patients I saw after getting briefed on the J&J decision was a young woman in her 30s.
She got the J&J vaccine a week ago. She had symptoms that overlap with those we were told to look out for. Today’s announcement changed my differential diagnosis & impacted my clinical management.
That’s exactly what it was meant to do. It’s also how we’ll get the data we need.
Look, let’s stop pretending that people don’t know the difference between vaccines. Or that potential issues with one vaccine means they won’t get the others if they’re available to them.
Will today’s announcement impact vaccine hesitancy? Perhaps. Maybe a bit. At most.
But more importantly, it should drastically improve our faith in the public health institutions tasked with protecting us. With how they had been politicized & over-ruled by the previous admin, this is critical.
And that’s exactly why I think today’s decision was the right one.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Right now wealthy countries like the US are sitting on millions of doses of this vaccine.
It’s not even authorized for use in the US, and won’t be for weeks.l at best.
A few days ago the US announced it would loan millions of doses to Canada & Mexico... npr.org/2021/03/19/979…
But we’re still sitting on millions of doses. And have ordered 300 million doses. Yes.
When the president pledged there would be enough vaccine for everyone eligible by the end of May, the AstraZeneca vaccine wasn’t even considered in the calculation.
The pace of vaccination has sped up dramatically in the past few months. We’re now averaging 2.5 million per day. And over 3 million vaccines were administered just today. 🎉
That’s incredible.
BUT we’re a huge country and even vaccinating 1% of the population in a day means it’ll take months to get everyone protected.
Only 42% of those >65 years old are fully vaccinated.
And only 13% of the US is fully vaccinated.
The majority of the US is still vulnerable to COVID.
In the last year I’ve done hundreds of TV interviews and lectures.
But yesterday a friend asked me to join her family’s Zoom call to answer questions and concerns about COVID-19 vaccines. It felt like the most important and impactful hour I’ve spent to date...
There were people from all over the country on the call. And they had such insightful and nuanced questions about the vaccines, but we’re struggling to separate the science from the misinformation on social media.
I completely understand why so many are still so uncertain...
But I could tell everyone felt much more reassured after our talk, especially when I shared how effective the vaccines were against getting severely ill, being hospitalized or dying from Covid. And also how excited I was to get my family vaccinated as well.
We need more clarity on what we’ll do with our huge surplus, and when. Sure, keep some for boosters, variants etc.
But we’re holding onto tens of millions of doses that we haven’t even authorized for use - and may never. reuters.com/article/us-hea…
What would I like to see?
Right now we’re sending out ~16 million doses weekly. That number will grow when more J&J is added at the end of the month and as capacity for the others picks up.
This ⤵️ examined the inequities of the global #COVID19 vaccine rollout. Wealthy nations need to help the rest of the world get vaccinated - not just for moral and humanitarian reasons, but also to tamp down variants and soften the global economic impact.
This ⤵️ outlined the precarious place we’re at in the pandemic. The next phase will depend on vaccines, variants, and how well we adhere to public health measures.
The recent lifting of restrictions & mask mandates may unnecessarily prolong the pandemic. link.medium.com/wCfDk8eCpeb
Learning the lessons from disease outbreaks is critical to improving response.
In our commentary for @TheLancet, @syramadad and I reflect on the lessons the U.S. learned responding to Ebola and how they could’ve better informed our #COVID19 response. 🧵